DK2646039T3 - Sammensætning og anvendelse deraf i behandlingen af analrhagader - Google Patents

Sammensætning og anvendelse deraf i behandlingen af analrhagader

Info

Publication number
DK2646039T3
DK2646039T3 DK12716670.0T DK12716670T DK2646039T3 DK 2646039 T3 DK2646039 T3 DK 2646039T3 DK 12716670 T DK12716670 T DK 12716670T DK 2646039 T3 DK2646039 T3 DK 2646039T3
Authority
DK
Denmark
Prior art keywords
rhada
anal
treatment
composition
application
Prior art date
Application number
DK12716670.0T
Other languages
English (en)
Inventor
Filippo Bastia
Maurizio Saccomanno
Original Assignee
Thd Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2646039(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thd Spa filed Critical Thd Spa
Application granted granted Critical
Publication of DK2646039T3 publication Critical patent/DK2646039T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/011Hydrolysed proteins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
DK12716670.0T 2012-01-30 2012-01-30 Sammensætning og anvendelse deraf i behandlingen af analrhagader DK2646039T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Publications (1)

Publication Number Publication Date
DK2646039T3 true DK2646039T3 (da) 2014-08-11

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12716670.0T DK2646039T3 (da) 2012-01-30 2012-01-30 Sammensætning og anvendelse deraf i behandlingen af analrhagader

Country Status (24)

Country Link
US (1) US9345747B2 (da)
EP (1) EP2646039B1 (da)
JP (1) JP5903505B2 (da)
KR (1) KR101599447B1 (da)
CN (2) CN104114177A (da)
AU (1) AU2012368815B2 (da)
BR (1) BR112014018850A8 (da)
CA (1) CA2863369C (da)
DK (1) DK2646039T3 (da)
ES (1) ES2485490T3 (da)
HK (1) HK1186378A1 (da)
HR (1) HRP20140594T1 (da)
IL (1) IL233875A (da)
IN (1) IN2014MN01733A (da)
MX (1) MX336204B (da)
PL (1) PL2646039T3 (da)
RS (1) RS53457B (da)
RU (1) RU2580622C2 (da)
SA (1) SA113340239B1 (da)
SG (1) SG11201404413UA (da)
SI (1) SI2646039T1 (da)
TW (1) TWI495476B (da)
WO (1) WO2013114410A1 (da)
ZA (1) ZA201405208B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6523291B2 (ja) 2013-12-24 2019-05-29 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company スキンケア有効成分の高い浸透性を与える美容組成物及び方法
ITRM20150163A1 (it) * 2015-04-17 2016-10-17 Uniderm Farm S R L Composizioni farmaceutiche per il trattamento delle ragadi anali
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
WO2020022991A2 (en) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Topical compositions for stretch marks on the skin
RU2771015C2 (ru) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Фармацевтическая композиция в виде мази для лечения геморроя

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
KR20010006358A (ko) * 1997-04-16 2001-01-26 라보라또아레 세로비오로지끄 (소시에떼 아노님) 오크라 종자에서 추출된 단백질 분획물이 화장품으로 사용되는 용도
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (zh) * 1998-04-28 1999-11-03 王京杭 组织修复促进剂
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2002204687A (ja) * 2000-11-09 2002-07-23 Onaka Yasushi β−1.3−1.6グルカン(アウレオバシジウム培養液)の医療、保健、福祉、食品および各種産業分野での応用
JP2003104832A (ja) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk 皮膚外用剤
JP4544500B2 (ja) * 2002-07-19 2010-09-15 一丸ファルコス株式会社 ヒアルロン酸合成促進剤
ES2423214T3 (es) * 2003-05-02 2013-09-18 Ceapro Inc. Composiciones farmacéuticas que comprenden el beta (1-3) beta (1-4) glucano de cereal
RU2277920C2 (ru) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой
ITMI20042111A1 (it) * 2004-11-04 2005-02-04 Biofarmitalia Spa Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia
JP5048935B2 (ja) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 保湿剤
DE202007004856U1 (de) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. CHM Anti Aging Komplex
CN101095482B (zh) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 制备膳食纤维食品用大麦麦麸或燕麦麦麸的制法
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds
ITUD20100112A1 (it) * 2010-06-09 2011-12-10 Farma Derma S R L Preparazione per uso vaginale e rettale e relativo procedimento di produzione
CN102084963A (zh) * 2010-09-29 2011-06-08 吉林省农业机械研究院 一种制备燕麦麦麸膳食纤维食品的方法

Also Published As

Publication number Publication date
MX336204B (es) 2016-01-11
EP2646039B1 (en) 2014-05-14
MX2014009244A (es) 2015-03-19
CA2863369A1 (en) 2013-08-08
JP5903505B2 (ja) 2016-04-13
AU2012368815A1 (en) 2014-09-18
PL2646039T3 (pl) 2014-10-31
CN104114177A (zh) 2014-10-22
HRP20140594T1 (hr) 2014-10-24
RU2580622C2 (ru) 2016-04-10
TWI495476B (zh) 2015-08-11
TW201334787A (zh) 2013-09-01
RU2014129391A (ru) 2016-03-27
SG11201404413UA (en) 2014-10-30
KR101599447B1 (ko) 2016-03-14
US9345747B2 (en) 2016-05-24
BR112014018850A8 (pt) 2017-07-11
ES2485490T3 (es) 2014-08-13
WO2013114410A1 (en) 2013-08-08
IN2014MN01733A (da) 2015-07-10
EP2646039A1 (en) 2013-10-09
RS53457B (en) 2014-12-31
AU2012368815B2 (en) 2018-03-01
HK1186378A1 (en) 2014-03-14
SI2646039T1 (sl) 2014-10-30
US20140303094A1 (en) 2014-10-09
KR20140127296A (ko) 2014-11-03
ZA201405208B (en) 2015-10-28
CN109865000A (zh) 2019-06-11
SA113340239B1 (ar) 2015-07-07
IL233875A0 (en) 2014-09-30
JP2015504915A (ja) 2015-02-16
CA2863369C (en) 2020-03-10
IL233875A (en) 2017-01-31
BR112014018850A2 (da) 2017-06-20

Similar Documents

Publication Publication Date Title
LTC3057969I2 (lt) Kompozicijos, naudojamos gydyti sutrikimams, susijusiems su kit
DK3335709T3 (da) Gamma-hydroxybutyratsammensætninger og deres anvendelse til behandling af lidelser
DK2882496T3 (da) Behandling og diagnosticering af melanom
DK2898061T3 (da) Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande
DK2903600T3 (da) Virusholdig formulering og anvendelse deraf
DK2920313T3 (da) Rekombinante adenovira og anvendelse deraf
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK2882441T3 (da) Behandling af immunrelaterede og inflammatoriske sygdomme
DK3076972T3 (da) Cancerbehandling med kombination af plinabulin og taxan
DK2815769T3 (da) Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
BR112014006291A2 (pt) composição e utilização da composição
DK2917181T3 (da) Heteroarylderivater og anvendelser deraf
DK3029038T3 (da) Tetrazolinonforbindelse og anvendelse deraf
DK2917231T3 (da) Lipopeptider til anvendelse ved behandling af leversygdomme og hjerte-kar-sygdomme
DK3326642T3 (da) Langtidsvirkende koagulationsfaktorer og brugen deraf
DK2854910T3 (da) Ceramidniveauer i behandling og forebyggelse af infektioner
DK2805670T3 (da) Forbedringer af og i sammenhæng med oftalmoskoper
DK3058936T3 (da) Peptidsammensætning og anvendelser deraf
DK2704744T3 (da) Komplementfaktor-b-analoger og anvendelser deraf
DK2914261T3 (da) Syntetisk letalitet og behandling af cancer
DK3074008T3 (da) Forbindelser, farmaceutisk sammensætning og fremgangsmåder til anvendelse i behandling af inflammation
DK2745849T3 (da) Polydeoxyribonukleotidsammensætning og anvendelser deraf
DK2854822T3 (da) Polysaccharidsammensætninger og fremgangsmåder til anvendelse
DK3019573T3 (da) Reaktionsharpiks-sammensætning og dennes anvendelse